P

ProQR Therapeutics NV
D

PRQR

2.45000
USD
0.21
(9.38%)
مغلق
حجم التداول
5,226
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
258,092,927
أصول ذات صلة الأخبار المقالات

العنوان: ProQR Therapeutics NV

القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.